Recent Updates
Recently added Catalysts
ZLAB

Zai Lab to Announce First Quarter 2022 Financial Results on May 10, 2022 – Zai Lab Limited

Wednesday, April 20, 2022 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Zai Lab to Announce First Quarter 2022 Financial Results on May 10, 2022 – Zai Lab Limited
Price reaction · baseline $45.12 (2022-04-19 close) · hit after-hours · 1 other ZLAB headline(s) in the window, move may be shared
day 0 close
-0.3%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.2%
average across 15 past catalysts
Cash runway
~28 mo
Low dilution risk
Lead asset
ZL-1310
Phase 3 · Small-cell Lung Cancer

Full Press Release Details

Zai Lab to Announce First Quarter 2022 Financial Results on May 10, 2022 – Zai Lab Limited.
ShareAdd on Google
Tags: ZLAB Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Apr 20, 2022

Biotech snapshot

Cash runway
$618M liquidity · $21M/mo burn
~28 mo
Low dilution risk
Lead asset
ZL-1310Phase 3
Small-cell Lung Cancer →

Catalyst track record

+60%
best trade around ZLAB's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for ZLAB.

See every catalyst's timing & PoA →